{
    "hands_on_practices": [
        {
            "introduction": "This first exercise establishes the fundamental calculations at the heart of therapeutic drug monitoring. By deriving the loading dose ($LD$) and maintenance dose ($MD$) from first principles, you will solidify your understanding of how to initiate and sustain a target drug concentration. Most importantly, this practice will challenge you to explain the distinct roles of volume of distribution ($V_d$) and clearance ($CL$), clarifying why an error in estimating one has very different clinical consequences than an error in the other .",
            "id": "4961351",
            "problem": "A single-compartment, linear pharmacokinetic model is assumed for an orally administered immediate-release drug. The goal is to achieve and maintain an average steady-state plasma concentration of $C_{\\text{target}} = 7.5$ mg/L in a clinically stable adult. The following parameters are known and scientifically justified based on prior population data for the drug:\n- Volume of distribution ($V_{d}$): $35$ L\n- Clearance ($CL$): $2.8$ L/h\n- Oral bioavailability ($F$) defined as the fraction of the administered dose that reaches the systemic circulation: $0.85$\n- Dosing interval ($\\tau$): $12$ h\n\nUsing only core pharmacokinetic definitions and mass-balance reasoning (no specialized shortcut formulas), determine:\n1. The oral loading dose ($LD$) that would instantaneously place the patient at the target concentration $C_{\\text{target}}$ at the time of absorption.\n2. The oral maintenance dose per dosing interval ($MD$) required to maintain the average steady-state concentration equal to $C_{\\text{target}}$ when dosed every $\\tau$.\n\nRound each of $LD$ and $MD$ to four significant figures. Express both answers in mg.\n\nThen, briefly explain, based on first principles, how systematic errors in estimating $V_{d}$ versus $CL$ would differentially affect the initial concentration after the loading dose and the long-term average steady-state concentration under maintenance dosing, assuming $F$ and $\\tau$ are correct. Your response should clearly distinguish the roles of $V_{d}$ and $CL$ in these outcomes.",
            "solution": "The problem is scientifically grounded, well-posed, objective, and contains all necessary information for a unique solution. The provided pharmacokinetic parameters are within a realistic range for a therapeutic drug. The problem will be solved by applying first principles of mass balance and core pharmacokinetic definitions.\n\n**1. Calculation of the Oral Loading Dose ($LD$)**\n\nThe loading dose ($LD$) is intended to rapidly achieve a target amount of drug in the body, which corresponds to the target plasma concentration ($C_{\\text{target}}$). The fundamental relationship between the amount of drug in the body ($A$) and the plasma concentration ($C$) is given by the definition of the volume of distribution ($V_{d}$):\n$$C = \\frac{A}{V_d}$$\nTherefore, to achieve a target concentration of $C_{\\text{target}}$, the required amount of drug in the body ($A_{\\text{target}}$) is:\n$$A_{\\text{target}} = C_{\\text{target}} \\cdot V_{d}$$\nThe problem specifies oral administration. The bioavailability, $F$, is the fraction of the administered oral dose that reaches the systemic circulation. Thus, the amount of drug that actually enters the body from an oral loading dose ($LD$) is $F \\cdot LD$.\nFor the amount of drug in the body to instantaneously reach $A_{\\text{target}}$ upon absorption, we must have:\n$$F \\cdot LD = A_{\\text{target}}$$\nSubstituting the expression for $A_{\\text{target}}$, we get the mass-balance equation for the loading dose:\n$$F \\cdot LD = C_{\\text{target}} \\cdot V_{d}$$\nSolving for $LD$:\n$$LD = \\frac{C_{\\text{target}} \\cdot V_{d}}{F}$$\nSubstituting the given values:\n-   $C_{\\text{target}} = 7.5 \\text{ mg/L}$\n-   $V_{d} = 35 \\text{ L}$\n-   $F = 0.85$\n$$LD = \\frac{(7.5 \\text{ mg/L}) \\cdot (35 \\text{ L})}{0.85} = \\frac{262.5 \\text{ mg}}{0.85} \\approx 308.8235 \\text{ mg}$$\nRounding to four significant figures, the loading dose is $308.8$ mg.\n\n**2. Calculation of the Oral Maintenance Dose ($MD$)**\n\nThe maintenance dose ($MD$) is designed to replace the amount of drug eliminated by the body over one dosing interval ($\\tau$), thereby maintaining the average concentration at a steady state. At steady state, the average rate of drug administration must equal the average rate of drug elimination.\n\nThe rate of drug elimination is governed by clearance ($CL$). Clearance is defined as the volume of plasma cleared of the drug per unit time. The rate of elimination (mass per time) is the product of clearance and plasma concentration ($C$):\n$$\\text{Rate of Elimination} = CL \\cdot C$$\nAt steady state, the concentration fluctuates, but the average rate of elimination over a dosing interval can be calculated using the average steady-state concentration, $C_{ss,avg}$. The problem requires this average to be the target concentration, $C_{\\text{target}}$.\n$$\\text{Average Rate of Elimination} = CL \\cdot C_{ss,avg} = CL \\cdot C_{\\text{target}}$$\nThe rate of drug administration is the amount of drug entering the systemic circulation per dosing interval, averaged over that interval. For an oral maintenance dose $MD$ with bioavailability $F$ given every $\\tau$ hours, the amount entering the circulation per dose is $F \\cdot MD$. The average rate of administration is:\n$$\\text{Average Rate of Administration} = \\frac{F \\cdot MD}{\\tau}$$\nEquating the average rates at steady state:\n$$\\frac{F \\cdot MD}{\\tau} = CL \\cdot C_{\\text{target}}$$\nSolving for $MD$:\n$$MD = \\frac{CL \\cdot C_{\\text{target}} \\cdot \\tau}{F}$$\nSubstituting the given values:\n-   $CL = 2.8 \\text{ L/h}$\n-   $C_{\\text{target}} = 7.5 \\text{ mg/L}$\n-   $\\tau = 12 \\text{ h}$\n-   $F = 0.85$\n$$MD = \\frac{(2.8 \\text{ L/h}) \\cdot (7.5 \\text{ mg/L}) \\cdot (12 \\text{ h})}{0.85} = \\frac{252 \\text{ mg}}{0.85} \\approx 296.4705 \\text{ mg}$$\nRounding to four significant figures, the maintenance dose is $296.5$ mg.\n\n**3. Impact of Errors in $V_{d}$ and $CL$**\n\nThe roles of volume of distribution ($V_{d}$) and clearance ($CL$) are distinct, and errors in their estimation have different consequences for the loading dose and maintenance dosing outcomes.\n\n**Effect on Initial Concentration after Loading Dose:**\nThe initial concentration achieved immediately after the absorption of the loading dose, $C_{0}$, is determined by the principle that the bioavailable dose ($F \\cdot LD$) fills the volume of distribution ($V_d$).\n$$C_{0} = \\frac{F \\cdot LD}{V_d}$$\nThe loading dose ($LD$) is calculated using an *estimated* $V_{d,est}$: $LD = (C_{\\text{target}} \\cdot V_{d,est}) / F$. Substituting this into the equation for the *actual* achieved concentration $C_0$ which depends on the *true* $V_d$:\n$$C_0 = \\frac{F}{V_d} \\left( \\frac{C_{\\text{target}} \\cdot V_{d,est}}{F} \\right) = C_{\\text{target}} \\cdot \\frac{V_{d,est}}{V_d}$$\nThis relationship shows that the achieved initial concentration $C_0$ is directly proportional to the estimated $V_{d,est}$ and inversely proportional to the true $V_d$.\n-   If $V_d$ is **overestimated** ($V_{d,est} > V_d$), the calculated $LD$ will be too large. This results in an achieved initial concentration $C_0$ that is **higher** than the target $C_{\\text{target}}$.\n-   If $V_d$ is **underestimated** ($V_{d,est} < V_d$), the calculated $LD$ will be too small, resulting in an achieved $C_0$ that is **lower** than $C_{\\text{target}}$.\nCritically, the parameter $CL$ does not appear in the equation for $C_0$. Therefore, an error in the estimation of $CL$ has **no effect** on the initial concentration achieved by the loading dose. $CL$ only governs how quickly the concentration declines *after* this initial level is achieved.\n\n**Effect on Average Steady-State Concentration:**\nThe average steady-state concentration ($C_{ss,avg}$) is determined by the balance between the rate of drug administration and the rate of drug elimination. As derived previously:\n$$C_{ss,avg} = \\frac{F \\cdot MD}{CL \\cdot \\tau}$$\nThe maintenance dose ($MD$) is calculated using an *estimated* $CL_{est}$: $MD = (CL_{est} \\cdot C_{\\text{target}} \\cdot \\tau) / F$. Substituting this into the equation for the *actual* achieved $C_{ss,avg}$ which depends on the *true* $CL$:\n$$C_{ss,avg} = \\frac{F}{CL \\cdot \\tau} \\left( \\frac{CL_{est} \\cdot C_{\\text{target}} \\cdot \\tau}{F} \\right) = C_{\\text{target}} \\cdot \\frac{CL_{est}}{CL}$$\nThis relationship shows that the achieved $C_{ss,avg}$ is directly proportional to the estimated $CL_{est}$ and inversely proportional to the true $CL$.\n-   If $CL$ is **overestimated** ($CL_{est} > CL$), the calculated $MD$ will be too large to compensate for a faster-than-actual perceived elimination. This results in an achieved $C_{ss,avg}$ that is **higher** than the target $C_{\\text{target}}$.\n-   If $CL$ is **underestimated** ($CL_{est} < CL$), the calculated $MD$ will be too small, resulting in an achieved $C_{ss,avg}$ that is **lower** than $C_{\\text{target}}$.\nCritically, the parameter $V_d$ does not appear in the equation for $C_{ss,avg}$. Therefore, an error in the estimation of $V_d$ has **no effect** on the average concentration achieved at steady state. An incorrect $V_d$ would alter the time to reach steady state and the magnitude of the fluctuations (peak and trough concentrations) around the average, but not the average value itself.\n\nIn summary, the loading dose and the initial concentration are governed by $V_d$, while the maintenance dose and the average steady-state concentration are governed by $CL$.",
            "answer": "$$\\boxed{\\begin{pmatrix} 308.8 & 296.5 \\end{pmatrix}}$$"
        },
        {
            "introduction": "Moving beyond single-dose calculations, this practice delves into the dynamics of a multiple-dose regimen. Here, you will derive and quantify two critical properties: the accumulation ratio ($R$) and the peak-to-trough fluctuation ($F$). This exercise illuminates how the interplay between a drug's elimination half-life ($t_{1/2}$) and the chosen dosing interval ($\\tau$) governs drug accumulation and the magnitude of concentration swings at steady state, providing the theoretical basis for designing stable and predictable dosing schedules .",
            "id": "4961345",
            "problem": "A clinician is designing a multiple-dose maintenance regimen for an intravenous bolus drug that follows a one-compartment model with first-order elimination, instantaneous distribution, and linear pharmacokinetics. Identical doses are administered at a fixed dosing interval $\\tau$. The drug has an elimination half-life $t_{1/2}$. Assume dosing continues until steady state is reached.\n\nRelying only on the exponential decay law for first-order elimination and the principle of superposition for linear systems, do the following:\n\n1. Define the accumulation ratio $R$ as the ratio of the steady-state peak concentration immediately after a dose to the peak concentration immediately after the very first dose. Derive an expression for $R$ in terms of $\\tau$ and $t_{1/2}$, then evaluate it for $\\tau = 12\\,\\mathrm{h}$ and $t_{1/2} = 6\\,\\mathrm{h}$.\n\n2. Define the peak-to-trough fluctuation over a dosing interval at steady state as the ratio $F$ of the steady-state peak concentration immediately after a dose to the trough concentration immediately before the next dose. Derive an expression for $F$ in terms of $\\tau$ and $t_{1/2}$, then evaluate it for $\\tau = 12\\,\\mathrm{h}$ and $t_{1/2} = 6\\,\\mathrm{h}$.\n\nExpress both final numerical values as dimensionless numbers and round each to $4$ significant figures. Provide your final answer as an ordered pair in the form $\\big(R, F\\big)$.",
            "solution": "The problem statement describes a standard scenario in pharmacokinetics and is well-posed, scientifically grounded, and internally consistent. All necessary parameters and principles for the derivation are provided. Therefore, the problem is valid. We shall proceed with the derivation.\n\nThe core principles to be used are the law of first-order elimination and the principle of superposition for linear systems.\n\nA single intravenous (IV) bolus dose $D$ administered at time $t=0$ into a one-compartment model with volume of distribution $V_d$ results in an initial plasma concentration $C_0 = \\frac{D}{V_d}$. Due to first-order elimination, the concentration at any subsequent time $t > 0$ is given by the exponential decay law:\n$$C(t) = C_0 \\exp(-k_e t)$$\nwhere $k_e$ is the first-order elimination rate constant. The constant $k_e$ is related to the elimination half-life $t_{1/2}$ by:\n$$k_e = \\frac{\\ln(2)}{t_{1/2}}$$\n\nA multiple-dose regimen consists of identical doses administered at a fixed dosing interval $\\tau$. The principle of superposition states that the total concentration at any time is the sum of the concentrations remaining from all previous doses.\n\nLet $C_{n,\\text{max}}$ be the peak concentration immediately after the $n$-th dose and $C_{n,\\text{min}}$ be the trough concentration immediately before the $n$-th dose.\nThe peak concentration after the first dose (at $t=0$) is $C_{1,\\text{max}} = C_0$.\nThe concentration just before the second dose (at $t=\\tau$) is $C_{2,\\text{min}} = C_{1,\\text{max}} \\exp(-k_e \\tau) = C_0 \\exp(-k_e \\tau)$.\nThe peak concentration after the second dose (at $t=\\tau$) is the sum of the new dose's concentration ($C_0$) and the residual concentration from the first dose:\n$$C_{2,\\text{max}} = C_0 + C_{2,\\text{min}} = C_0 + C_0 \\exp(-k_e \\tau) = C_0 (1 + \\exp(-k_e \\tau))$$\nFollowing this pattern, the peak concentration after the $n$-th dose is a geometric series:\n$$C_{n,\\text{max}} = C_0 \\sum_{i=0}^{n-1} (\\exp(-k_e \\tau))^i$$\n\nAt steady state ($n \\to \\infty$), the peak concentration $C_{\\text{ss,max}}$ is the sum of this infinite geometric series. Since $k_e > 0$ and $\\tau > 0$, the common ratio $r = \\exp(-k_e \\tau)$ satisfies $0 < r < 1$. The sum converges to:\n$$C_{\\text{ss,max}} = \\lim_{n\\to\\infty} C_{n,\\text{max}} = C_0 \\sum_{i=0}^{\\infty} (\\exp(-k_e \\tau))^i = C_0 \\frac{1}{1 - \\exp(-k_e \\tau)}$$\n\nThe steady-state trough concentration, $C_{\\text{ss,min}}$, is the concentration just before the next dose, which is the steady-state peak concentration decayed over one dosing interval $\\tau$:\n$$C_{\\text{ss,min}} = C_{\\text{ss,max}} \\exp(-k_e \\tau) = C_0 \\frac{\\exp(-k_e \\tau)}{1 - \\exp(-k_e \\tau)}$$\n\nWith these expressions, we can derive the required quantities.\n\n1.  **Accumulation Ratio ($R$)**\n    The accumulation ratio $R$ is defined as the ratio of the steady-state peak concentration to the peak concentration after the first dose.\n    $$R = \\frac{C_{\\text{ss,max}}}{C_{1,\\text{max}}}$$\n    Substituting the expressions for $C_{\\text{ss,max}}$ and $C_{1,\\text{max}} = C_0$:\n    $$R = \\frac{C_0 \\frac{1}{1 - \\exp(-k_e \\tau)}}{C_0} = \\frac{1}{1 - \\exp(-k_e \\tau)}$$\n    To express this in terms of $\\tau$ and $t_{1/2}$, we substitute $k_e = \\frac{\\ln(2)}{t_{1/2}}$:\n    $$R = \\frac{1}{1 - \\exp\\left(-\\frac{\\ln(2)}{t_{1/2}} \\tau\\right)} = \\frac{1}{1 - \\exp\\left(\\ln\\left(2^{-\\tau/t_{1/2}}\\right)\\right)} = \\frac{1}{1 - 2^{-\\tau/t_{1/2}}}$$\n    We are given $\\tau = 12\\,\\mathrm{h}$ and $t_{1/2} = 6\\,\\mathrm{h}$. The ratio $\\frac{\\tau}{t_{1/2}} = \\frac{12}{6} = 2$.\n    $$R = \\frac{1}{1 - 2^{-2}} = \\frac{1}{1 - \\frac{1}{4}} = \\frac{1}{\\frac{3}{4}} = \\frac{4}{3}$$\n    As a decimal, $R = 1.3333...$. Rounding to $4$ significant figures gives $R \\approx 1.333$.\n\n2.  **Peak-to-Trough Fluctuation ($F$)**\n    The peak-to-trough fluctuation $F$ is defined as the ratio of the steady-state peak concentration to the steady-state trough concentration.\n    $$F = \\frac{C_{\\text{ss,max}}}{C_{\\text{ss,min}}}$$\n    Substituting the expressions for $C_{\\text{ss,max}}$ and $C_{\\text{ss,min}}$:\n    $$F = \\frac{C_0 \\frac{1}{1 - \\exp(-k_e \\tau)}}{C_0 \\frac{\\exp(-k_e \\tau)}{1 - \\exp(-k_e \\tau)}} = \\frac{1}{\\exp(-k_e \\tau)} = \\exp(k_e \\tau)$$\n    To express this in terms of $\\tau$ and $t_{1/2}$, we again substitute $k_e = \\frac{\\ln(2)}{t_{1/2}}$:\n    $$F = \\exp\\left(\\frac{\\ln(2)}{t_{1/2}} \\tau\\right) = \\exp\\left(\\ln\\left(2^{\\tau/t_{1/2}}\\right)\\right) = 2^{\\tau/t_{1/2}}$$\n    Using the given values, $\\frac{\\tau}{t_{1/2}} = 2$.\n    $$F = 2^2 = 4$$\n    As a decimal rounded to $4$ significant figures, $F = 4.000$.\n\nThe final answer is the ordered pair $(R, F)$.",
            "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n1.333 & 4.000\n\\end{pmatrix}\n}\n$$"
        },
        {
            "introduction": "This final practice synthesizes the preceding concepts into a comprehensive regimen design challenge. Faced with a therapeutic goal and a set of practical constraints, you must make a strategic choice for the dosing interval ($\\tau$) to minimize concentration fluctuation while ensuring the dose remains within safe limits. This exercise models the real-world decision-making process of a clinical pharmacologist, requiring you to integrate theory and calculation to devise a complete and optimized dosing strategy, including both loading and maintenance doses .",
            "id": "4961340",
            "problem": "A single-compartment, linear pharmacokinetic model is used to guide dosing of an immediate-release oral drug for a patient. Absorption into the central compartment is effectively instantaneous relative to elimination, distribution is instantaneous, and elimination is first-order. The following are known:\n- Oral bioavailability: $F = 0.60$.\n- Clearance: $\\mathrm{CL} = 6.0\\ \\mathrm{L}\\ \\mathrm{h}^{-1}$.\n- Apparent volume of distribution: $V_{d} = 140\\ \\mathrm{L}$.\n- Desired average steady-state concentration: $\\bar{C}_{\\mathrm{ss}} = 5.0\\ \\mathrm{mg}\\ \\mathrm{L}^{-1}$.\n\nOperational constraints:\n- Maximum maintenance dose per administration is $D_{\\max} = 500\\ \\mathrm{mg}$.\n- Dosing frequency cannot exceed three doses per $24\\ \\mathrm{h}$ (equivalently, the dosing interval $\\tau$ cannot be less than $8\\ \\mathrm{h}$).\n\nUsing only the core definitions of clearance, amount–concentration relationships in a one-compartment model, and first-order elimination, design a dosing regimen that minimizes steady-state peak–trough fluctuation subject to the given constraints and achieves the target average steady-state concentration. Specifically:\n- Choose the dosing interval $\\tau$ to minimize fluctuation without violating the frequency constraint.\n- Compute the required maintenance dose per administration (Maintenance Dose (MD)) so that the average steady-state concentration equals $\\bar{C}_{\\mathrm{ss}}$.\n- Compute a single Loading Dose (LD) to be given at time $t=0$ so that the concentration immediately after the loading dose equals the target average steady-state concentration.\n\nExpress both LD and MD in $\\mathrm{mg}$. Round both to four significant figures. Report your final answer in the order $\\big[$LD, MD$\\big]$.",
            "solution": "The problem statement has been validated and found to be scientifically grounded, well-posed, objective, and internally consistent. It presents a standard pharmacokinetic scenario with a clear objective and sufficient data to derive a unique solution.\n\nThe analysis proceeds by applying first principles of one-compartment, linear pharmacokinetics. The model assumes instantaneous absorption and distribution, with first-order elimination.\n\nFirst, we determine the first-order elimination rate constant, $k_e$. This parameter is fundamentally related to clearance ($\\mathrm{CL}$) and the apparent volume of distribution ($V_d$) by the definition of clearance:\n$$\n\\mathrm{CL} = k_e \\cdot V_d\n$$\nSolving for $k_e$:\n$$\nk_e = \\frac{\\mathrm{CL}}{V_d} = \\frac{6.0\\ \\mathrm{L}\\ \\mathrm{h}^{-1}}{140\\ \\mathrm{L}} = \\frac{3}{70}\\ \\mathrm{h}^{-1} \\approx 0.042857\\ \\mathrm{h}^{-1}\n$$\n\nThe primary objective is to minimize the steady-state peak–trough fluctuation. For a one-compartment model with multiple oral doses, the peak ($C_{\\mathrm{ss,max}}$) and trough ($C_{\\mathrm{ss,min}}$) concentrations at steady state are related by the decay over one dosing interval, $\\tau$:\n$$\nC_{\\mathrm{ss,min}} = C_{\\mathrm{ss,max}} \\cdot \\exp(-k_e \\tau)\n$$\nThe fluctuation is often quantified by the ratio of peak to trough concentration:\n$$\n\\text{Fluctuation Ratio} = \\frac{C_{\\mathrm{ss,max}}}{C_{\\mathrm{ss,min}}} = \\frac{1}{\\exp(-k_e \\tau)} = \\exp(k_e \\tau)\n$$\nTo minimize this ratio, since $k_e$ is a positive constant, we must minimize the dosing interval $\\tau$. The problem specifies a constraint on dosing frequency: no more than three doses per $24\\ \\mathrm{h}$, which is explicitly defined as $\\tau \\ge 8\\ \\mathrm{h}$. Therefore, the value of $\\tau$ that minimizes fluctuation while adhering to this constraint is the minimum possible value:\n$$\n\\tau = 8\\ \\mathrm{h}\n$$\n\nNext, we compute the required Maintenance Dose (MD) to achieve the desired average steady-state concentration, $\\bar{C}_{\\mathrm{ss}} = 5.0\\ \\mathrm{mg}\\ \\mathrm{L}^{-1}$. The average concentration at steady state is defined as the total drug exposure over one dosing interval (Area Under the Curve, $\\mathrm{AUC}_{\\tau,\\mathrm{ss}}$) divided by the length of the interval, $\\tau$. A fundamental relationship in pharmacokinetics states that $\\mathrm{AUC}_{\\tau,\\mathrm{ss}}$ is equal to the bioavailable dose divided by clearance:\n$$\n\\bar{C}_{\\mathrm{ss}} = \\frac{\\mathrm{AUC}_{\\tau,\\mathrm{ss}}}{\\tau} = \\frac{(F \\cdot \\mathrm{MD}) / \\mathrm{CL}}{\\tau} = \\frac{F \\cdot \\mathrm{MD}}{\\mathrm{CL} \\cdot \\tau}\n$$\nwhere $F$ is the oral bioavailability. We can rearrange this equation to solve for MD:\n$$\n\\mathrm{MD} = \\frac{\\bar{C}_{\\mathrm{ss}} \\cdot \\mathrm{CL} \\cdot \\tau}{F}\n$$\nSubstituting the given values:\n$$\n\\mathrm{MD} = \\frac{(5.0\\ \\mathrm{mg}\\ \\mathrm{L}^{-1}) \\cdot (6.0\\ \\mathrm{L}\\ \\mathrm{h}^{-1}) \\cdot (8\\ \\mathrm{h})}{0.60} = \\frac{240}{0.60}\\ \\mathrm{mg} = 400\\ \\mathrm{mg}\n$$\nThis calculated dose of $400\\ \\mathrm{mg}$ must be checked against the operational constraint $D_{\\max} = 500\\ \\mathrm{mg}$. Since $400\\ \\mathrm{mg} \\le 500\\ \\mathrm{mg}$, this maintenance dose is valid.\n\nFinally, we compute the single Loading Dose (LD). The problem specifies that the concentration immediately after the loading dose, $C_0$, must equal the target average steady-state concentration, $\\bar{C}_{\\mathrm{ss}}$. The initial concentration resulting from an oral dose is the total amount of drug that enters the systemic circulation, $F \\cdot \\mathrm{LD}$, distributed throughout the apparent volume of distribution, $V_d$:\n$$\nC_0 = \\frac{F \\cdot \\mathrm{LD}}{V_d}\n$$\nSetting $C_0 = \\bar{C}_{\\mathrm{ss}}$ as per the problem's requirement:\n$$\n\\bar{C}_{\\mathrm{ss}} = \\frac{F \\cdot \\mathrm{LD}}{V_d}\n$$\nSolving for LD:\n$$\n\\mathrm{LD} = \\frac{\\bar{C}_{\\mathrm{ss}} \\cdot V_d}{F}\n$$\nSubstituting the given values:\n$$\n\\mathrm{LD} = \\frac{(5.0\\ \\mathrm{mg}\\ \\mathrm{L}^{-1}) \\cdot (140\\ \\mathrm{L})}{0.60} = \\frac{700}{0.60}\\ \\mathrm{mg} = \\frac{3500}{3}\\ \\mathrm{mg} \\approx 1166.66... \\mathrm{mg}\n$$\nThe problem requires rounding the final answers to four significant figures.\nThe Maintenance Dose (MD) is exactly $400\\ \\mathrm{mg}$, which is written as $400.0\\ \\mathrm{mg}$ to show four significant figures.\nThe Loading Dose (LD) of $1166.66...\\ \\mathrm{mg}$ rounds to $1167\\ \\mathrm{mg}$.\n\nThe resulting dosing regimen is:\n- Loading Dose (LD) = $1167\\ \\mathrm{mg}$\n- Maintenance Dose (MD) = $400.0\\ \\mathrm{mg}$\n- Dosing Interval ($\\tau$) = $8\\ \\mathrm{h}$",
            "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n1167 & 400.0\n\\end{pmatrix}\n}\n$$"
        }
    ]
}